The brain-immune cells axis controls tissue specific immunopathology.
Name:
Heyner, Schreier and Kröger.pdf
Size:
299.0Kb
Format:
PDF
Description:
original manuscript
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2019-02-01
Metadata
Show full item recordAbstract
During viral infections, cell death can be induced as a direct result of cytopathic virus replication in various cell types and tissues or as an immune response of the host to the infectious agent. This leads to an infiltration of inflammatory cells, causing subsequent tissue damage. The balance between effective elimination of the pathogen and prevention of fatal tissue damage is decisive for life. The host has developed various mechanisms to inhibit excessive immune responses. Glucocorticoids (GCs) are well known to inhibit the immune response. GCs are synthesized after activation of the hypothalamic–pituitary–adrenal (HPA) axis by various viral infections and systemic inflammation. Neurons in the hypothalamus express the corticotropin-releasing hormone (CRH). CRH in turn induces a signaling cascade, which ends with an activation and release of GCs in the adrenal cortex.1 GCs can act as suppressors or inducers of the immune system by binding to the glucocorticoid receptor (GR) (Fig. 1). The HPA axis is activated in response to various viral infections or systemic inflammation, and is required to restore homeostasis by limiting inflammation and tissue damage. The underlying mechanisms remained unclear so far.Citation
Cell Mol Immunol. 2019 Feb;16(2):101-103. doi: 10.1038/s41423-018-0176-y. Epub 2018 Nov 7.Affiliation
HZI, Helmholtz Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig Germany.Publisher
Dpringer-NaturePubMed ID
30405148Type
ArticleLanguage
enISSN
2042-0226ae974a485f413a2113503eed53cd6c53
10.1038/s41423-018-0176-y
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Commentary: Endogenous glucocorticoids control host resistance to viral infection through tissue-specific regulation of PD-1 expression on NK cells.
- Authors: Thomsen AR
- Issue date: 2019 Mar
- Glucocorticoids and NK cell PD-1.
- Authors: Biron CA
- Issue date: 2018 Sep
- Neuroendocrine control of natural killer cell function through the checkpoint molecule PD-1.
- Authors: Devulder J, Tsicopoulos A, Duez C
- Issue date: 2019 Feb
- The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance.
- Authors: Schönrich G, Raftery MJ
- Issue date: 2019
- The role of T-cell-mediated mechanisms in virus infections of the nervous system.
- Authors: Dörries R
- Issue date: 2001